MoneyWorks4Me

Sandu Pharmaceuticals informs about certificate

08 Apr 2022 Evaluate

In Compliance with Regulation 74(5) of SEBI (Depository and Participant) Regulation 2018, Sandu Pharmaceuticals has forwarded a copy of certificate received by them from Link Intime India, the Registrar and Share Transfer Agents of the Company for the Quarter ended 31st March 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..